India’s ‘Biotech Queen’ Doubles Down on Drug Access

Known as India’s ‘Queen of Biotech’, Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world’s biggest producers of insulin, and a leading force in biosimilars. As she looks… Known as India’s ‘Queen of Biotech’, Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world’s biggest producers of insulin, and a leading force in biosimilars. As she looks at handing over her life’s work to successors, Mazumdar-Shaw talks to Bloomberg’s Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future. (Source: Bloomberg)